The 80% researcher position in the CRISPR gene therapy group led by Emma Haapaniemi is based at NCMBM, University of Oslo & Oslo University Hospital. We welcome applications from recent PhD graduates and experienced scientists alike.

The successful candidate will optimize and scale up protocols for efficient mutation correction in human T cells and hematopoietic stem cells using CRISPR-Cas9. Tasks include high-throughput assay development, setting up sequencing libraries, and advancing workflows